Effect of oxymatrine on hepatic gene expression profile in experimental liver fibrosis of rats

Chinese Journal of Integrative Medicine

Volumn 18, Issue 6, 2012, Pages 445-450

  Jian, Yi Cheng ^a   Li, Wei ^a   He, Yi ^a   Jiang, Ming ^a   Liu, Yan Bing ^a   Xiong, Wu Jun ^a  

^a Key Laboratory of Arrhythmias of Ministry of Education   (China)

Author keywords

Gene chip; Liver fibrosis; Oxymatrine

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; COLLAGEN TYPE 1; CYTOCHROME P450; EARLY GROWTH RESPONSE FACTOR; GLYCOLIPID; HYALURONIC ACID; INTEGRIN; LAMININ; OLIGONUCLEOTIDE; OXYMATRINE; SODIUM CHLORIDE;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOTRANSFORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; EXTRACELLULAR FLUID; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; LIVER FIBROSIS; LIVER FUNCTION; MALE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ALKALOIDS; ANIMALS; DOWN-REGULATION; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; QUINOLIZINES; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; TRANSCRIPTOME; UP-REGULATION;

EID: 84867307281     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-012-1115-x     Document Type: Article

References (16)

1. Deng ZY, Li J, Jin Y, Chen XL, Lu XW. Effect of oxymatrine on the p38 mitogen-activated protein kinases signaling pathway in rats with CCl4 induced hepatic fibrosis. Chin Med J 2009;122:1449-1454.
2. Wu XL, Zeng WZ, Jiang MD, Qin JP, Xu H. Effect of Oxymatrine on the TGF beta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis. World J Gastroenterol 2008;14:2100-2105.
3. Shi GF, Li Q. Effects of oxymatrine on experimental hepatic fibrosis and its mechanism in vivo. World J Gastroenterol 2005;11:268-271.
4. Wu CS, Piao XX, Piao DM, Jin YR, Li CH. Treatment of pig serum-induced rat liver fibrosis with Boschniakia rossica, oxymatrine and interferon-alpha. World J Gastroenterol 2005;11:122-126.
5. Yu XH, Zhu JS, Yu HF, Zhu L. Immunomodulatory effect of oxymatrine on induced CCl4-hepatic fibrosis in rats. Chin Med J 2004;117:1856-1858.
6. Mao YM, Zeng MD, Lu LG, Wan MB, Li CZ, Chen CW, et al. Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study. World J Gastroenterol 2004;10:3269-3273.
7. Lin M, Yang LY, Li WY, Peng YP, Zheng JK. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine. J Int Med Res 2009;37:1411-1149.
8. Cheng Y, Ping J, Xu HD, Fu HJ, Zhou ZH. Synergistic effect of a novel oxymatrine-baicalin combination against hepatitis B virus replication, alpha smooth muscle actin expression and type I collagen synthesis in vitro. World J Gastroenterol 2006;12:5153-5159.
9. Liu J, Manheimer E, Tsutani K, Gluud C. Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials. Am J Gastroenterol 2003;98:538-544.
10. Kang YJ. Herbogenomics: from traditional Chinese medicine to novel therapeutics. Exp Biol Med 2008;233:1059-1065.
11. Zhang JP, Zhang M, Zhou JP, Liu FT, Zhou B, Xie WF, et al. Antifibrotic effects of matrine on in vitro and in vivo models of liver fibrosis in rats. Acta Pharmacol Sin 2001;22:183-186.
12. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13:372-374.
13. Quondamatteo F, Kempkensteffen C, Miosge N, Sonnenberg A, Herken R. Ultrastructural localization of integrin subunits alpha 3 and alpha 6 in capillarized sinusoids of the human cirrhotic liver. Histol Histopathol 2004;19:799-806.
14. Gressner OA, Gressner AM. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int 2008;28:1065-1079.
15. Pritchard MT, Nagy LE. Ethanol-induced liver injury: potential roles for egr-1. Alcohol Clin Exp Res 2005;29:146S-150S.
16. Kim ND, Moon JO, Slitt AL, Copple BL. Early growth response factor-1 is critical for cholestatic liver injury. Toxicol Sci 2006;90:586-595.